Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Saturday
Mar 13th
Home arrow Farmavita.Net Journal arrow Business Reports
Farmavita.Net - Business Reports
Print E-mail
Market Report

datamonitor_logo.gif

Gastric Cancer - Targeted therapies compete for first-to-market status

Gastric cancer incidence in 2009 is forecast to be 197,000 in the seven major pharmaceutical markets (US, Japan, Germany, France, Italy, Spain, and UK). Although, the global incidence has decreased in recent years, mortality remains high, particularly in the US and Europe. Therefore, predictably a high unmet need remains for effective therapies to improve mortality.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Pharmaceuticals: Global Industry Almanac

Datamonitor's Pharmaceuticals: Extended Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Schizophrenia - Second generation depots protect market value

Schizophrenia is a chronic and severe mental health disorder affecting around 4.6 million schizophrenia sufferers across the seven major markets. Currently led by oral branded atypical antipsychotics, the schizophrenia market will undergo some big changes over the period 2008/2017. Prospective players can expect to face stiff competition from generic versions of all currently branded drugs.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors

The market for CNS drugs across the 7MM was worth a substantial $95.5 billion, accounting for a 21.4% share of the total pharmaceutical market value in 2007. Despite stalling R&D productivity and the genericization of the majority of leading CNS blockbuster brands, the market continues to offer a wealth of lucrative opportunities for all types of drug manufacturer.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Pricing and Reimbursement in The United Arab Emirates

The healthcare sector in the emirates of Abu Dhabi and Dubai is undergoing drastic changes as a result of the structural and financing reforms that will impact all major actors in the healthcare sector.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges

In recent years, Pharma has begun to adapt its business model in response to growing industry constraints and the decline of the primary-care focused blockbuster therapy. This process of change has recently been disrupted by unprecedented challenges caused by the global economic downturn, and by President Obama's planned overhaul of the US healthcare system.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Generic Benchmarking: Brand Erosion at Patent Expiry

Not only is Pharma facing a continued slow down in sales growth in the seven major markets, but erosion of branded drugs by generics follow patent expiry is increasing, driven by evolving payer initiatives to incentivize generic use.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifTuberculosis - Development pipeline shows signs of life

Tuberculosis is a major cause of illness and death worldwide, but despite 14.4 million prevalent cases, 9.2 million new cases and 1.7 million deaths in 2006, the small and rapidly declining burden of disease in the seven major markets has limited drug and vaccine development activities until recently.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Healthcare Technology Opportunities in the Electronic Health Record Market (Review Report)


Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 73 - 81 of 324
Advertisement
 

Featured Video

More videos ...

3D Content Cloud

Featured Partners

farmavita_research-store.gif
top-20-cancer-therapy-brand.jpg
generics-growth-strategies2.gif
sfe_eu10_150x150_v2.gif 
mddexeceu10_150x150_v1.gif
discovery2010_150x150.gif
150x150_salesonco-master.gif
pharma_omaeu10_150x150_v2.gif
risksharingnextlevel.gif 
arriello-150x150.gif 
150x150_ceepr3_master.gif 
pharmabrand2010_150x150.gif
 

Login to Farmavita.Net

membership is FREE

Follow us on:

bpe_oglas.gif




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 6 guests online

Farmavita.Net RSS News


Products

Click to Products

JobLine

Click here ...Post a Job for Free

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS